Menu

Private Equity and Venture Capital


Overview

Private Equity and Venture Capital Entity Representation

Carlton Fields represents PE and VC entities in connection with formation and fund investment transactions, investments and acquisitions for portfolio companies, and compliance with all federal and state securities laws and regulations.

These services include:

  • Structuring and forming PE and VC funds, as well as hedge funds, and including the negotiation of lockups and exit strategies
  • Representing clients in capital raising activities (including seed capital arrangements with sponsors) and ensuring their compliance with securities laws
  • Negotiating terms of manager’s duties, obligations, and compensation
  • Advising and assisting clients in connection with registration requirements or exemptions from registration under the Investment Advisers Act of 1940 (registered investment advisers), as well as corresponding state securities laws
  • Advising and assisting clients in compliance with broker/dealer registration requirements or exemptions from registration under federal and state securities laws
  • Assisting entities that become registered investment advisors in establishing the policies and infrastructure necessary to comply with regulatory reporting requirements
  • Representing PE and VC funds with investments in, or acquisitions of, portfolio companies
  • Representing PE and VC funds in connection with their ownership and operation of portfolio companies, including advising on fiduciary duties and conflicts that may arise from their investments
  • Structuring and negotiating acquisition transactions for clients’ portfolio companies

Private Equity and Venture Capital Portfolio Company Representation

Carlton Fields represents PE and VC portfolio companies that operate in areas as diverse as technology, biotech, industrial and biomedical manufacturing, wireless devices, and application software. Our work includes representing drug discovery and medical device companies, and we are experienced in clinical trial representation and FDA matters.

Our services on behalf of high-growth-potential new ventures include:

  • Business planning 
  • Choice of entity structuring and formation 
  • Corporate housekeeping and governance
  • Private debt offerings and syndicated loans 
  • Seed and angel financings 
  • Technology transfer 
  • Creation and protection of intellectual property 
  • Licensing 
  • Employment matters 
  • Operational issues of all types

Our services include preparing and negotiating:

  • Complex securities purchase agreements and investment agreements
  • Stockholder agreements establishing the contractual arrangements between the investors, issuers, and founders, including:
    • rights of first refusal
    • co-sale and drag-along rights
    • voting agreements
    • board of director composition
    • information requirements
    • rights of first offer
  • Preferred stock designations, rights, and preferences
  • Registration rights agreements
  • Warrant agreements
  • Debt instruments, including convertible promissory notes
  • Loan documentation for private equity lending transactions

As companies grow, our services expand to include: 

  • Relationship contracts 
  • Venture capital financing including equity, debt, and convertible securities 
  • Mergers, consolidations, and acquisitions (in both acquisition and exit transactions)
  • Initial and secondary public offerings 
  • Divestitures 
  • SEC compliance

Disclaimer

The information on this website is presented as a service for our clients and Internet users and is not intended to be legal advice, nor should you consider it as such. Although we welcome your inquiries, please keep in mind that merely contacting us will not establish an attorney-client relationship between us. Consequently, you should not convey any confidential information to us until a formal attorney-client relationship has been established. Please remember that electronic correspondence on the internet is not secure and that you should not include sensitive or confidential information in messages. With that in mind, we look forward to hearing from you.